Neeraj Tolmare
Known title: DirectorCIK: 0002006183
Associated companies
Transaction History
| CROX | ▲ Buy | Grant | 1,252 | $0 | 6/9/2026 | View on chart |
| CROX | ▲ Buy | Grant | 1,095 | $0 | 6/9/2026 | View on chart |
| CROX | ▲ Buy | Grant | 1,521 | $0 | 6/10/2025 | View on chart |
| CROX | ▲ Buy | Grant | 1,331 | $0 | 6/10/2025 | View on chart |
| CROX | ▲ Buy | Grant | 1,075 | $0 | 6/4/2024 | View on chart |
| CROX | ▲ Buy | Grant | 806 | $0 | 6/4/2024 | View on chart |
| CROX | ▲ Buy | Grant | 681 | $0 | 1/2/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Crocs (CROX) Announces Q3 2026 Earnings Call, Cites Growth
The company scheduled a conference call to discuss its third‑quarter 2026 earnings. Management highlighted accelerating international sales and expects continued growth in North America. A new partnership with BARK expands the brand into pet‑focused products, starting with a customizable dog bed. Recent commentary notes that Crocs' exposure to oil prices has diminished, improving cost stability.
Crocs (CROX) Announces Q3 2026 Earnings Call, Cites Growth. The company scheduled a conference call to discuss its third‑quarter 2026 earnings. Management highlighted accelerating international sales and expects continued growth in North America. A new partnership with BARK expands the brand into pet‑focused products, starting with a customizable dog bed. Recent commentary notes that Crocs' exposure to oil prices has diminished, improving cost stability.